Research for a Future
without Diabetes

„Research for a future without diabetes – this is the mission of the DZD that inspires and unites us.“

Prof. Martin Hrabě de Angelis, DZD board member

Research for a Future
without Diabetes

"The DZD stands for research to benefit people with diabetes."

Prof. Andreas Birkenfeld, DZD-Sprecher

„The Germany-wide cooperation in the DZD ensures that multicenter studies can be carried out with the required number of participants.“

Prof. Michael Roden, DZD board member


Research for a Future
without Diabetes

„The DZD places particular importance on the fast transfer of lab results to patient care.“

Prof. Michele Solimena, DZD speaker



Research for a Future
without Diabetes

„The special feature of research at the DZD is the close interdisciplinary cooperation between different disciplines.“

Prof. Annette Schuermann, DZD Speaker

DZD - German Center
for Diabetes Research

Berlin/Neuherberg, 27.05.2022

DZD Scientist Stephan Herzig Awarded with the Werner Creutzfeldt Prize

For his outstanding achievements in the research field “Diabetes and Cancer”, the German Diabetes Society (DDG) awards this year's Werner Creutzfeldt Prize to Helmholtz Munich scientist Stephan Herzig.

Stephan Herzig is the scientific director of the Helmholtz Diabetes Center and research director of Helmholtz Munich. He also heads the Institute of Diabetes and Cancer at Helmholtz Munich. After his PhD in molecular pharmacology, he started his scientific career as a postdoc at the Salk Institute in the US from 2000 to 2003. From 2004, he established an independent junior research group at the German Cancer Research Center (DKFZ) in Heidelberg. In 2010, he was appointed department head and full Pprofessor of the DKFZ and the medical faculty. In 2015, he moved to Helmholtz Munich, where he remains today. Stephan Herzig holds a chair at the Technical University of Munich (TUM) and is honorary professor at the medical faculty of Heidelberg University.

His research focuses on the molecular basis of metabolic control and the identification of new therapeutic options in diabetes and cancer. He is receiving the Werner Creutzfeldt Prize for his work on “Regulatory and transcriptional networks in diabetes as well as the crosstalk between metabolism and cancer”.

Stephan Herzig has already been awarded numerous prizes: the Marie Curie Excellence Award of the European Union in 2005, the Ferdinand Bertram Prize of the German Diabetes Association in 2007, the Richtzenhain Prize for Translational Cancer Research of the DKFZ in 2010, the Reinhardt Koselleck Prize of the DFG in 2012, and the Research Prize of the German Liver Foundation in 2015.

About the award
The Werner Creutzfeldt Prize of the DDG, endowed with 10,000 euros and donated by the company Lilly Deutschland GmbH, is awarded to researching physicians and scientists for extraordinary work in the field of pathophysiology and therapy of diabetes mellitus, with a special focus on the field of "gastrointestinal hormones".

About Helmholtz Munich 
Helmholtz Munich is a leading biomedical research center. Its mission is to develop breakthrough solutions for better health in a rapidly changing world. Interdisciplinary research teams focus on environmentally triggered diseases, especially the therapy and prevention of diabetes, obesity, allergies and chronic lung diseases. With the power of artificial intelligence and bioengineering, the researchers accelerate the translation to patients. Helmholtz Munich has more than 2,500 employees and is headquartered in Munich/Neuherberg. It is a member of the Helmholtz Association, with more than 43,000 employees and 18 research centers the largest scientific organization in Germany. More about Helmholtz Munich (Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH):     


Press contact

Birgit Niesing

+49 (0)89 3187-3971

Prof. Dr. Stephan Herzig. © Helmholtz Munich